Stock GLS GLENMARK LIFE SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Glenmark Life Sciences Limited

Equities

GLS

INE03Q201024

End-of-day quote NSE India S.E.
Other stock markets
 18:00:00 2024-05-16 EDT 		5-day change 1st Jan Change
834 INR +0.73% Intraday chart for Glenmark Life Sciences Limited +0.76% +26.93%
05-15 Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion RE
04-25 Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
RE
Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024
Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Glenmark Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Glenmark Life Sciences Limited Announces Resignation of Gita Nayyar as Non-Executive, Independent Director
CI
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.
CI
Glenmark Life Sciences Limited Announces Board Resignations, Effective March 6, 2024
CI
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.
CI
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24
AQ
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs
RE
Transcript : Glenmark Life Sciences Limited, Q3 2024 Earnings Call, Jan 24, 2024
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO
RE
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Paracetamol maker Granules India posts marginal rise in Q3 profit
RE
Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API
MT
Glenmark Life Sciences Announces Another CDMO Deal
CI
India's Glenmark Pharma posts Q2 loss on exceptional legal costs
RE
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand
RE
Transcript : Glenmark Life Sciences Limited, Q2 2024 Earnings Call, Oct 20, 2023
India's Glenmark Life Sciences posts Q2 profit rise on API boost
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLS Stock
  4. News Glenmark Life Sciences Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW